Dear Reader,
10 Companies to Watch in 2026
2025 was the year AIM showed its resilience, rising nearly 10pc after enduring years of higher interest rates in the wake of the pandemic and continued economic and geopolitical uncertainty.
10 Companies to Watch in 2026
2025 was the year AIM showed its resilience, rising nearly 10pc after enduring years of higher interest rates in the wake of the pandemic and continued economic and geopolitical uncertainty.
10 Companies to Watch in 2026
2025 was the year AIM showed its resilience, rising nearly 10pc after enduring years of higher interest rates in the wake of the pandemic and continued economic and geopolitical uncertainty.
Shortwave Life Sciences Plc (AQSE: PSY) PSYCH Symposium London 2025
PSYCH Symposium London 2025: Shortwave Life Sciences to Present Emerging Clinical Research as Gold Partner
Share Talk Weekly Stock Market News Review, Sunday 9th November 2025
London’s FTSE 100 closed at its lowest level in almost two weeks on Friday, dragged lower by steep losses in property and travel stocks. The blue-chip index ended 53 points,
Shortwave Life Sciences (AQSE: PSY) publishes patent application for buccal film formation
Shortwave Life Sciences PLC (PSY), listed on the Aquis Stock Exchange Growth Market, the UK’s leading healthcare company focused on developing innovative treatments for anorexia nervosa, is pleased to announce
Share Talk Weekly Stock Market News Review, Sunday 28th September 2025
The broader market was quiet for small-cap stocks this week. The AIM All-Share index rose slightly, gaining fewer than two points to close at 775.68. This was a marginal outperformance
Shortwave Life Sciences PLC (AQSE: PSY) Appointment digital asset treasury partner Archax
Company appoints digital asset treasury management partner Archax
Shortwave Life Sciences: Real Assets, Digital & Healthcare Innovation — An Investor Report
This investor report provides a detailed assessment of the strategic reset announced by Shortwave Life Sciences following a recent interview with the company’s executive leadership .
RNS Hotlist with Zak Mir: MAST, FDR, GEO, ROCK, WSBN, RCR, GGP, AMG, TGP, CHLL, ECOB, ANP, FDEV, PR1, PSY & KDNC
Yesterday MAST Energy Developments (MAST) announced that it has been made aware of articles recommending the Company and its shares to investors which appear to be “sponsored articles” on websites
Shortwave Life Sciences (AQSE: PSY) £250K Raised, Biotech Meets Digital Assets
StockBox spoke to Shortwave Life Sciences co-founder Stephen Murphy and executive chairman Rolf Gerritsen following the company’s £250,000 fundraise. They discussed the company’s strategic expansion into digital asset management, upcoming